retatrutide clinical trial news Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 Tirzepatide vs. Retatrutide: Key Differences

Patients with comorbidities such as renal impairment or cardiovascular disease may require adjustments to their dosage regimen to mitigate potential risks and optimize therapeutic benefits

E., Cao, X., Streutker, C

What is warranted is neither dismissal nor enthusiasm, but serious attention

Your healthcare provider should supervise this transition to monitor for side effects and adjust your plan if needed

#FDAApproval #GLP1 #Obesity #MetabolicHealth #OralTherapies #PharmaInnovation #ClinicalDevelopment #PatientCentricity #NovoNordisk #WeightManagement #HealthcareTransformation To view or add a comment, sign in The oral GLP-1 era has officially begun

Evolv GLP-1 has not gone through that same process it's regulated as a dietary supplement, not a drug, which means its efficacy claims aren't held to the same evidentiary standard